StockData
Polaryx Therapeutics, Inc. logo

Polaryx Therapeutics, Inc. (PLYX) stock

PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.60−0.07 (-4.19%)

Close on Nov 17, 2026Market cap $79.75MP/E –Yield –

Polaryx Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Polaryx Therapeutics's total assets was $8.61M at Sep 30, 2026. For fiscal 2025 it was $5.17M, up 3.4% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.17M+3.4%
FY2024Dec 31, 2024$5.00M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$8.61M+72.2%
Q2 FY2026Jun 30, 2026$11.81M–
Q1 FY2026Mar 31, 2026$3.50M–
Q4 FY2025Dec 31, 2025$5.17M–
Q4 FY2024Dec 31, 2024$5.00M–

More Polaryx Therapeutics figures

See a number that looks wrong?